C
Originally published by Capital News
📰 Read Full Article
top
September 26, 2025
4h ago

Gates Foundation Partners with Indian Manufacturer to Make HIV Prevention Injection Affordable

Gates Foundation Partners with Indian Manufacturer to Make HIV Prevention Injection Affordable

New partnership will join others to expand access to generic lenacapavir for millions more people at risk of HIV in high-burden countries—bringing the world closer to ending the epidemic - Kenya breaking news | Kenya news today | Capitalfm.co.ke..

✨ Key Highlights

The Gates Foundation has partnered with Indian manufacturer Hetero Labs to make a low-cost, generic version of lenacapavir, the world’s first twice-yearly injectable HIV prevention drug, accessible to millions in low- and middle-income countries.

  • The generic lenacapavir will be manufactured at approximately $40 per patient per year, making it affordable for national health systems.
  • This partnership is supported by upfront funding and volume guarantees from the Gates Foundation, complementing existing agreements for initial supply.
  • Another Indian manufacturer, Dr. Reddy's Laboratories Ltd. (DRL), also joined efforts to build a competitive generics ecosystem, with large-scale generic supply anticipated as early as 2027.

Continue Reading

Read the complete article from Capital News

📰 Read Full Article

Related News